Some providers featured on this site may compensate us. This may affect the order and placement of listings but does not influence our editorial ratings or reviews.
Treatments Hub

Verified prices

All verified prices
Guide6 min read

SHED Cost 2026: Pricing the Guarantee - $199 Decoded

SHED costs $199/month for semaglutide, $299 for tirzepatide, 20% off month one. What the premium over $49 GLP-1 rivals actually buys: coaching plus a guarantee.

Updated September 15, 2026

Medically reviewed on

How we review

Key takeaways

  • SHED costs $199/month for compounded semaglutide and $299/month for tirzepatide, each with 20% off the first month (~$159 / ~$239 to start).
  • The price bundles the provider visit, the medication and health coaching, backed by a lose-5%-in-120-days-or-your-money-back guarantee - no consultation fee, no separate membership.
  • Priced apart, the bundle is fair: budget-tier semaglutide runs $41-$99, standalone coaching commonly $50-100+/month, and nobody else sells a results guarantee.
  • HSA/FSA approval shrinks the premium: $199 in pre-tax dollars costs a 24%-bracket taxpayer an effective ~$151, and the first-month discount lands month one near budget-tier pricing.

Sticker, discount, and first-month math

Bottom line firstSHED runs $199/month for compounded semaglutide and $299/month for tirzepatide, each with 20% off your first month (~$159 / ~$239 to start). The price includes the provider visit, the medication, and health coaching - and it's HSA/FSA approved, backed by a lose-5%-in-120-days-or-your-money-back guarantee.

No hidden consultation fee, no separate membership - the number is the number. The only asterisk worth writing: the guarantee has adherence conditions, on their site.

Decomposing the $199

The clarifying exercise for any premium product - price the components separately. Compounded semaglutide with clinical oversight trades for $41-$99/month across our budget tier. Structured health coaching, bought standalone, commonly runs $50-100+/month anywhere in wellness. A money-back results policy has no standalone market price - it's an insurance product nobody else sells. Add it up and $199 stops looking like an expensive medication and starts looking like a fairly-priced bundle - for the person who uses all three parts. Skip the coaching, and you're overpaying by design.

ProviderSemaglutideTirzepatideBundled extras
welludr$41/mo$71/moCoach, warranty
embody$49/mo$99/moRefund if not approved
altRx$89/mo$149/moBrand shelf, BNPL
HealthRx$125/mo*$199Overnight shipping
Medvi$99/mo promo (reg. $199)$166/mo promo (reg. $299)Video visits, dietician
SHED$199/mo$299/moCoaching + money-back guarantee

*After a $39 first month.

Shop GLP-1 plans by product

The lowest published plans - cheapest first, conditions under each price.

Is SHED HSA/FSA eligible?

SHED is explicitly HSA/FSA approved, and this is where its premium quietly shrinks: paying $199 with pre-tax dollars costs a person in the 24% bracket an effective ~$151. Run your own bracket before comparing stickers - the gap to mid-market providers narrows more than most shoppers expect. Stack the first-month 20% on top and month one lands near budget-tier pricing.

Is SHED worth it?

Ask yourself: if the program didn't exist and someone handed me the vial, would I succeed? If yes - you're a medication customer; buy at $41 and thrive. If honestly no - if structure, a coach, and stakes are what turned past attempts around or their absence is what sank them - then SHED's premium is buying the thing that actually determines your outcome, with your money back if it doesn't. That's a rational $140/month for the right person, and a wasted one for the wrong person.

→ Full SHED review with plan details

This article is general information, not medical advice. Prices as listed at the time of writing - confirm current pricing on the provider's site.

Ready to compare weight loss providers?

See how top providers stack up on pricing, medical support, and treatment options.

Medical disclaimer

This page is general information about GLP-1 weight-loss medications such as semaglutide and tirzepatide, published to help you compare services. It is not medical advice, it does not create a doctor-patient relationship, and it is not a substitute for a consultation with a licensed clinician who knows your history. Treatments Hub is not a medical provider, pharmacy or clinic and does not prescribe, sell or dispense medication. Do not start, stop or change any treatment because of something you read here, and do not delay seeking care; in an emergency call 911.

Semaglutide and tirzepatide carry an FDA boxed warning about thyroid C-cell tumours seen in rodents and are not for anyone with a personal or family history of medullary thyroid carcinoma or MEN 2, nor for use in pregnancy. Compounded versions sold by telehealth providers are prepared by state-licensed pharmacies and are not FDA-approved products. Where a review or post on this page mentions weight lost, that is one person's result and is not typical; results vary widely.

Medical and scientific statements on this site are checked against the sources linked on the page by our medical content reviewer, who does not choose providers or set prices. Prices, plans and customer reviews are each provider's published figures and customers' own words on the dates stated. We may earn a commission from provider links. The full medical and advertising disclaimer explains all of this in detail.

Sources & medical references

Treatment facts on this page are grounded in regulatory guidance and peer-reviewed research. Pricing and plan details come from each provider's published information. This content is for information only and is not medical advice - always consult a licensed clinician before starting treatment.

  1. 1.Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 trial) - New England Journal of Medicine, 2021
  2. 2.Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1 trial) - New England Journal of Medicine, 2022
  3. 3.FDA Approves New Drug Treatment for Chronic Weight Management (semaglutide / Wegovy) - U.S. Food & Drug Administration, 2021
  4. 4.FDA Approves New Medication for Chronic Weight Management (tirzepatide / Zepbound) - U.S. Food & Drug Administration, 2023
  5. 5.FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss - U.S. Food & Drug Administration
  6. 6.Human Drug Compounding (503A pharmacy standards) - U.S. Food & Drug Administration
  7. 7.Semaglutide Injection - drug information - MedlinePlus, U.S. National Library of Medicine (NIH)